pubmed-article:7017568 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7017568 | lifeskim:mentions | umls-concept:C0021289 | lld:lifeskim |
pubmed-article:7017568 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:7017568 | lifeskim:mentions | umls-concept:C0042874 | lld:lifeskim |
pubmed-article:7017568 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:7017568 | lifeskim:mentions | umls-concept:C0011155 | lld:lifeskim |
pubmed-article:7017568 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:7017568 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:7017568 | pubmed:dateCreated | 1981-8-10 | lld:pubmed |
pubmed-article:7017568 | pubmed:abstractText | Blood from full-term newborns was compared to adult blood for its ability to regenerate prostaglandin I2 (PGI2)-like activity from vascular tissue. The neonate possesses a markedly decreased ability to regenerate PGI2 (0.10 4/- 0.07 ng/mg vascular tissue) when compared to the adult (0.42 +/- 0.12). This decreased activity was not due to the presence of an inhibitor in neonatal blood. The impaired ability of neonatal blood to regenerate PGI2-like activity was related to its markedly decreased antioxidant potential and was corrected (0.34 +/- 0.08 ng/mg vascular tissue) by the addition of Vitamin E in vitro. Plasma PGI2-like regenerating activity had normalized by 3 to 5 months of age (0.41 +/- 0.11 ng/mg). | lld:pubmed |
pubmed-article:7017568 | pubmed:language | eng | lld:pubmed |
pubmed-article:7017568 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7017568 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7017568 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7017568 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7017568 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7017568 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7017568 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7017568 | pubmed:month | Jun | lld:pubmed |
pubmed-article:7017568 | pubmed:issn | 0031-3998 | lld:pubmed |
pubmed-article:7017568 | pubmed:author | pubmed-author:StuartM JMJ | lld:pubmed |
pubmed-article:7017568 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7017568 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:7017568 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7017568 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7017568 | pubmed:pagination | 971-3 | lld:pubmed |
pubmed-article:7017568 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:7017568 | pubmed:meshHeading | pubmed-meshheading:7017568-... | lld:pubmed |
pubmed-article:7017568 | pubmed:meshHeading | pubmed-meshheading:7017568-... | lld:pubmed |
pubmed-article:7017568 | pubmed:meshHeading | pubmed-meshheading:7017568-... | lld:pubmed |
pubmed-article:7017568 | pubmed:meshHeading | pubmed-meshheading:7017568-... | lld:pubmed |
pubmed-article:7017568 | pubmed:meshHeading | pubmed-meshheading:7017568-... | lld:pubmed |
pubmed-article:7017568 | pubmed:meshHeading | pubmed-meshheading:7017568-... | lld:pubmed |
pubmed-article:7017568 | pubmed:meshHeading | pubmed-meshheading:7017568-... | lld:pubmed |
pubmed-article:7017568 | pubmed:year | 1981 | lld:pubmed |
pubmed-article:7017568 | pubmed:articleTitle | Deficiency of plasma PGI2-like regenerating activity in neonatal plasma. Reversal by vitamin E in vitro. | lld:pubmed |
pubmed-article:7017568 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7017568 | pubmed:publicationType | In Vitro | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7017568 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7017568 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7017568 | lld:pubmed |